Streamline Health Solutions (NASDAQ:STRM) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued to investors on Friday. The firm set a “sell” rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Stock Performance

STRM opened at $2.00 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 0.61. The company has a market cap of $124.06 million, a PE ratio of -6.25 and a beta of 1.60. The stock has a 50-day moving average of $4.66 and a 200-day moving average of $5.76. Streamline Health Solutions has a 52-week low of $2.00 and a 52-week high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last announced its earnings results on Wednesday, September 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The company had revenue of $4.48 million for the quarter.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.